Sitra

SET Ventures, established in 2007 and based in Amsterdam, Netherlands, is a venture capital firm focusing on early to growth-stage investments in Europe. The company specializes in digital technology for a carbon-free energy system, backing pioneering startups with sustainable solutions and a strong digital DNA. Its investment priority lies in sectors such as distributed infrastructure, energy retail, buildings, mobility, industry, and enabling technologies. SET Ventures typically invests between €0.5 million to €6 million per portfolio company, aiming to take a seat on the supervisory board.

Headai Ltd. specializes in the development of software robots that automate a range of intellectual tasks for businesses. Founded in 2015 and based in Pori, Finland, the company provides a cloud service featuring teachable robots that can assist with everyday operations, corporate learning, and content discovery tailored to individual interests. Utilizing advanced algorithms that incorporate natural language processing and self-organized learning, Headai's technology enables clients to uncover insights from large datasets and recognize previously hidden connections. The software robots are designed to be interactive and adaptable, allowing organizations to streamline repetitive processes and improve efficiency in their operations.

Naava specializes in developing living green walls technology aimed at improving indoor air quality and enhancing overall well-being. By utilizing bioactive plants, Naava creates environments that purify air, reduce harmful chemicals, and provide natural humidity, making it easier for individuals and businesses to incorporate the benefits of nature into their indoor spaces. The company's innovative solutions address the need for healthier living and working environments, especially as people spend a significant portion of their time indoors, often exposed to synthetic air. Naava's mission is to reconnect people with nature, allowing them to experience the refreshing quality of Nordic forest air, even in urban settings.

Optomeditech Oy, established in June 2011, specializes in developing and marketing medical devices, particularly intravenous catheters and blood collection needles. The company focuses on enhancing patient safety and improving healthcare outcomes for both patients and caregivers. Its innovative devices utilize transillumination technology to assist in cannulation, thereby increasing the success rate of first-time procedures for healthcare professionals. Currently, Optomeditech is working towards obtaining CE mark and FDA 510(k) approval for its inaugural IV catheter product, with plans to enter the market in the first half of 2015.

NaturVention Enclosed Ecosystem Technologies solves global problems by combining nature and technology. We are a fast growing, venture-backed technology company. We challenge ourselves to find solutions to global problems by looking into nature, from where we have been able to find solutions for thousands of years already. We have developed patented solutions by enhancing nature’s own processes. We use the brightest technology to enhance those processes in order to create products that are easy to use and which help people to feel better by providing clean and healthy air and food.

Omegawave develops innovative training and performance management solutions aimed at enhancing athletic performance while minimizing the risk of injuries and overtraining. The company's electronic device measures cardiac, metabolic, and central nervous system activity, allowing athletes to assess their physiological readiness in a quick, non-invasive manner. This assessment provides valuable insights into how their body is responding to prior exertion and helps optimize future training sessions. Omegawave's technology is integrated into training regimens, offering coaches real-time data critical for understanding their athletes' needs. Its products are utilized by various Olympic Federations, top soccer teams, and franchises across major North American sports leagues, as well as individual athletes. In recognition of its contributions to elite sports, Omegawave received the award for the 'Best Performance Technology for Elite Athletes' at the Sports Technology Awards in 2014.

VisionPlus is a Finnish venture capital firm established in 2011, located in Helsinki. The firm focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment portfolio encompasses software-as-a-service, mobile applications, and internet services, as well as special content intellectual property deals. The management team at VisionPlus possesses extensive experience in technology, entrepreneurship, and seed investments, having successfully developed and managed large-scale business and development organizations in a global context.

Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, it focuses on developing and marketing navigated transcranial magnetic stimulation (nTMS) systems, utilizing its proprietary SmartFocus technology with 3D navigation for precise targeting of brain regions. The company offers the NBT system for treating major depressive disorder and chronic neuropathic pain, as well as the NBS system for pre-surgical mapping of speech and motor cortices. Nexstim primarily serves universities and teaching hospitals, with a significant portion of its revenue generated in North America and its products marketed across Europe and internationally.

Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, it focuses on developing and marketing navigated transcranial magnetic stimulation (nTMS) systems, utilizing its proprietary SmartFocus technology with 3D navigation for precise targeting of brain regions. The company offers the NBT system for treating major depressive disorder and chronic neuropathic pain, as well as the NBS system for pre-surgical mapping of speech and motor cortices. Nexstim primarily serves universities and teaching hospitals, with a significant portion of its revenue generated in North America and its products marketed across Europe and internationally.

FIT Biotech is a biotechnology company focused on developing and commercializing its proprietary Gene Transport Unit (GTU®) technology, which has applications in DNA vaccination and immunotherapy. The company specializes in creating antibody therapies for cancer treatment and DNA vaccines aimed at preventing infectious diseases, including HIV. By leveraging its innovative technology, FIT Biotech enables clients to stimulate the human body to produce antibodies naturally, rather than relying on industrially manufactured alternatives. This approach positions the company at the forefront of advancements in biopharmaceutical services, particularly in the fields of gene therapy and vaccine development.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.

The company develops and delivers technology for converting ocean waves to electricity. AW-Energy has developed WaveRoller - a fully submerged wave energy converter which utilizes wave surge phenomenon. This commonplace effect is observed in near-shore waters where the circular motion of water particles present in open sea waves changes into elliptical circulation due to more shallow bottom. Before the waves break, typically at the depth of 8-20 metres this elliptical motion is so flat that it is essentially a horizontal back-and-forth movement of water. WaveRoller device is a Panel anchored at its base on the sea bed. The back and forth movement of the wave surge moves the Panel, transferring the kinetic energy to piston pumps. The pumps create a great deal of pressure which is fed into a combination of hydraulic motor/generator, which in turn produces electricity. The nominal capacity of a single commercial-scale Panel ranges between 500 – 1000 kW, depending on the wave resources available on the site. WaveRoller has the ability to generate energy on a wide spectrum of wave states and is also well suited for locations where wave periods are long and the swell is strong. A series of WaveRoller devices can be combined into an array, thus resulting in a wave farm. Since the plant construction is modular with a high degree of independence between individual units, there is no natural upper limit to the number of WaveRoller units that can be used, therefore offering a high level of scalability and reliability. The electricity output from an individual Panel is connected to a hub/substation, thus making it easy to plug-in new units in separate project development stages, as the new capacity is added to the farm. Also, any potential underperformance or service & maintenance breaks of individual units have no impact on the remaining units, thus ensuring uninterrupted power output from the overall farm. The first prototypes were designed and patent applications were filed as early as in 1999, when Rauno Koivusaari, the original inventor co-operated with Fortum Research Centre during the conceptual phase. Since then the technology has evolved following numerous laboratory and wave-tank test trials and ongoing mathematical simulations. Open sea trails started in 2004 and included the Gulf of Finland, marine tests conducted in the European Marine Energy Centre (EMEC), Scotland, and an own testing site in Peniche, Portugal. The subsequent successes and encouraging test results led to continuous increase in the scale of the demonstration plant. The latest demonstration plant/farm consisting of three 100kW WaveRoller units (total nominal capacity of the farm 300kW) is to be deployed in Peniche, Portugal, during the second quarter of 2012. The final assembly is nearing completion in the first quarter of 2012 and will be awaiting suitable weather conditions for the deployment in the following months. The farm will be connected to national grid in Portugal. The company has already secured all the necessary permits and, additionally, holds a licence for 1MW grid connection.